CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- 4 Grant or award Director acquired 922 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, Chief Technical Ops. Off. acquired 14,112 shares (grant or award)
- 4 Grant or award Director acquired 1,001 shares (grant or award)
- 4 Grant or award Director acquired 501 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,001 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,001 shares (grant or award)
- 4 Planned sale Director sold 467 shares at $402.95 ($188,178)
- 4 Derivatives Options or other derivatives
- 4 Planned sale SVP & Chief Accounting Officer sold 240 shares at $419.00 ($100,560)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 3,309 shares (to pay taxes)
- 4 Planned sale EVP, Chief Reg. & Quality Off. sold 354 shares at $425.70 ($150,698)
- 4 Planned sale EVP Chief Patient & Ext Af Off sold 3,004 shares at $425.70 ($1,278,803)
- 4 Shares withheld for taxes CEO & President gave up 9,386 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CMO gave up 3,309 shares (to pay taxes)
- 4 Planned sale EVP, Chief Technical Ops. Off. sold 883 shares at $425.70 ($375,893)
Page 13 of 129 · 2,568 filings